Cover Image
市場調查報告書

美國的POCT (就地檢驗) 市場:2015∼2019年

POCT Market in the US 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 345513
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
美國的POCT (就地檢驗) 市場:2015∼2019年 POCT Market in the US 2015-2019
出版日期: 2015年11月18日 內容資訊: 英文 70 Pages
簡介

由於糖尿病和心臟病,肥胖等文明病的發病率、罹患率上升,POCT受到關注。POCT將診斷中的錯誤控制在最小限度患者,成本效益高,在提高患者生活品質上擔負著重要角色。預計美國的POCT市場2014∼2019年以年複合成長率5.88%擴大。

本報告提供美國的POCT市場相關調查、該市場的現狀與至2019年的成長前景、市場趨勢與課題、主要供應商的概要與等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要

第6章 美國的醫療改革

  • PPACA的引進
  • 波特的五力分析

第7章 各用途市場市場區隔

  • 血糖檢驗
  • 傳染病檢查
  • 心臟標記檢驗
  • 血液凝固檢驗
  • 妊娠檢驗,妊娠檢驗
  • 血氣/電解質檢驗
  • 腫瘤標記(癌症篩檢)檢驗
  • 尿液檢查
  • 膽固醇檢驗

第8章 推動市場的要素

  • 北美自由貿易組織(NAFTA)的影響
  • 急速且自動化診斷的需求
  • 在家的POCT
  • 技術創新
  • 聯合與M&A使技術發展

第9章 促進要素的影響

第10章 市場課題

第11章 促進要素與課題的影響

第12章 市場趨勢

第13章 供應商環境

  • 競爭模式
  • Abbott Diagnostics
  • Alere
  • Roche Diagnostics
  • Siemens Diagnostics
  • 其他值得注意的供應商

第14章 主要供應商分析

第15章 附錄

第16章 關於Technavio

圖表

目錄
Product Code: IRTNTR7799

About POCT

POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays a major role in improving patients' quality of life.

The methods of POCT include meters or monitors and strips. The POCT diagnostic devices are of two types: bedside and near-bedside monitoring devices. The bedside POCT devices are small and offer mobility whereas the near-bedside POCT devices are large and complex. These devices are used to test cardiac biomarkers, blood coagulation, platelet function, HIV, hemoglobin concentration, ad five-part differential blood count.

Technavio's analysts forecast the POCT market in the US to grow at a CAGR of 5.88% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the POCT market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of POCT diagnostic devices. The market is segmented based on application:

  • Blood glucose testing
  • Infectious disease testing
  • Cardiac markers testing
  • Pregnancy and fertility testing
  • Blood gas/electrolyte testing
  • Tumour markers testing
  • Urinalysis testing
  • Cholesterol testing

Technavio's report, POCT Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the key vendors in the market. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.

Key vendors

  • Abbott diagnostics
  • Alere
  • Roche Diagnostics
  • Siemens Diagnostics

Other Prominent Vendors

  • Abaxis
  • Acon Laboratories
  • Avioq
  • Bio-Rad Laboratories
  • Cavidi
  • Cepheid
  • Chembio Diagnostic Systems
  • Clarity Diagnostics
  • Hologic
  • i-Sens
  • Landwind Medical
  • Mindray
  • Nipro Diagnostics
  • Randox Laboratories
  • Span Diagnostics
  • Sysmex
  • Thermo Fisher Scientific
  • Trivitron Healthcare
  • URIT

Market driver

  • North America free trade agreement
  • For a full, detailed list, view our report

Market challenge

  • Limitation of POCT products
  • For a full, detailed list, view our report

Market trend

  • Key role of USAMRIID
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview

PART 06: Healthcare reform in US

  • Introduction of PPACA
  • Five forces analysis

PART 07: Market segmentation by application

  • Blood glucose testing market in US
  • Infectious disease testing market in US
  • Cardiac marker testing market in US
  • Coagulation testing market in US
  • Pregnancy and fertility testing market in US
  • Blood gas/electrolyte testing market in US
  • Tumor marker testing market in US
  • Urinalysis testing market in US
  • Cholesterol testing market in US

PART 08: Market drivers

  • Influence of NAFTA
  • Demand for rapid and automated diagnostics
  • POCT at home
  • Technological innovations
  • Collaborations and M&A to enhance POCT technology

PART 09: Impact of drivers

PART 10: Market challenges

  • Issues of intellectual property rights
  • Threat of low-cost products
  • Product recalls

PART 11: Impact of drivers and challenges

PART 12: Market trends

  • Shift toward patient-centered model
  • Low-cost microfluidic devices for POCT
  • Growing popularity of portable POCT products
  • Role of USAMRIID

PART 13: Vendor landscape

  • Competitive scenario
  • Abbott Diagnostics
  • Alere
  • Roche Diagnostics
  • Siemens Diagnostics
  • Other prominent vendors

PART 14: Key vendor analysis

  • Abbott Diagnostics
  • Alere
  • Roche Diagnostics
  • Siemens Healthcare

PART 15: Appendix

  • List of abbreviations

PART 16: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: POCT market in US 2014-2019 ($ millions)
  • Exhibit 03: PPACA benefits for US citizens
  • Exhibit 04: Comparison of US healthcare provision pre and post reform
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Segmentation of POCT market in US by application
  • Exhibit 07: Blood glucose testing market in US 2014-2019 ($ millions)
  • Exhibit 08: Infectious disease testing market in US 2014-2019 ($ millions)
  • Exhibit 09: Cardiac marker testing market in US 2014-2019 ($ millions)
  • Exhibit 10: Coagulation testing market in US 2014-2019 ($ millions)
  • Exhibit 11: Pregnancy and fertility testing market in US 2014-2019 ($ millions)
  • Exhibit 12: Blood gas/electrolyte testing market in US 2014-2019 ($ millions)
  • Exhibit 13: Tumor marker testing market in US 2014-2019 ($ millions)
  • Exhibit 14: Urinalysis testing market in US 2014-2019 ($ millions)
  • Exhibit 15: Cholesterol testing market in US 2014-2019 ($ millions)
  • Exhibit 16: Segmentation of POCT market in US by application 2014POCT market in US by application 2014
  • Exhibit 17: Impact of drivers
  • Exhibit 18: Impact of drivers and challenges
  • Exhibit 19: Abbott Diagnostics: Key takeaways
  • Exhibit 20: Alere: Key takeaways
  • Exhibit 21: Roche Diagnostics: Key takeaways
  • Exhibit 22: Siemens Diagnostics: Key takeaways
  • Exhibit 23: Abbott Diagnostics: Key business offerings
  • Exhibit 24: Alere: Business Segmentation by revenue 2014
  • Exhibit 25: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 26: Alere: Geographical segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 27: Roche Diagnostics: Business segmentation by revenue 2014
  • Exhibit 28: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 29: Roche Diagnostics: Geographical segmentation by revenue 2014
  • Exhibit 30: Siemens Healthcare: Business segmentation
  • Exhibit 31: Siemens Healthcare: Geographical segmentation by revenue 2014
Back to Top